| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6120770 | Journal of Clinical Virology | 2013 | 5 Pages |
Abstract
Fluctuation in circulating HCV-RNA may be clinically meaningful in a substantial proportion of chronic hepatitis C patients. It may influence the best time to prescribe antiviral therapy. Moreover, decisions based on early viral kinetics, such as early stopping rules, may require testing of baseline specimens the closest to treatment initiation.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Pablo Barreiro, Pablo Labarga, José V. Fernández-Montero, Eva Poveda, Carmen de Mendoza, Clara Sánchez, Eugenia Vispo, Vincent Soriano,